Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

IRIX stock hub

IRIDEX Corporation has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

IRIXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

17.9M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

IRIX

In the news

Latest news · IRIX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-126.4

P25 -105.6P50 -46.5P75 -3.1

ROIC-19.8

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All IRIX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

211

Groups with data

Currency

USD

Showing 211 of 211 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001006045
Company name	IRIDEX Corporation
Country	United States
Country code	US
Cusip	462684101
Employees	93
Employees Change	-18%
Employees Change Percent	-16.22
Enterprise value	$16.4M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Devices
IPO Date	1996-02-15
Isin	US4626841013
Last refreshed	2026-05-10
Market cap	$17.9M
Market cap category	Nano-Cap
Price	$1.03
Price currency	USD
Rev Per Employee	566,397.85x
Sector	Healthcare
Sic	3845
Symbol	IRIX
Website	https://www.iridex.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-24.76%
EV Sales Forward	0.3x
EV/Sales	0.31x
FCF yield	-12.6%
P/B ratio	3.64x
P/S ratio	0.34x
PS Forward	0.33x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-4.88%
EBITDA Margin	-4.4%
Gross margin	36.5%
Gross Profit	$19.2M
Gross Profit Growth	-1.41%
Gross Profit Growth Q	-1.95%
Gross Profit Growth3 Y	-8.83%
Gross Profit Growth5 Y	4.33%
Net Income	$-4.4M
Net Income Growth Quarters	5%
Net Income Growth Years	2%
Pretax Margin	-8.32%
Profit Margin	-8.42%
Profit Per Employee	$-47,710
ROA	-5.51
Roa5y	-12.16
ROCE	-16.13
ROE	-126.4
Roe5y	-82.86
ROIC	-19.85

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-21.15%
Cagr15y	-8.38%
Cagr1y	-10.44%
Cagr20y	-11.82%
Cagr3y	-23.26%
Cagr5y	-33.3%
EPS Growth Quarters	5
EPS Growth Years	2
Revenue Growth	8.23x
Revenue Growth Q	15.97x
Revenue Growth Quarters	5x
Revenue Growth Years	1x
Revenue Growth3 Y	-2.58x
Revenue Growth5 Y	7.7x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$1.81
Assets	$29.2M
Cash	$6M
Current Assets	$25.3M
Current Liabilities	$13.2M
Debt	$4.5M
Debt Equity	$0.92
Equity	$4.9M
Liabilities	$24.2M
Long Term Assets	$3.9M
Long Term Liabilities	$11M
Net Cash	$1.5M
Net Cash By Market Cap	$8.35
Net Debt Equity	$-0.3
Tangible Book Value	$-3M
Tangible Book Value Per Share	$-0.17
WACC	6.23

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.91
Inventory Turnover	3.58
Net Working Capital	$6.7M
Quick ratio	1.18
Working Capital	$12M
Working Capital Turnover	$5.53

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.01%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-90.71%
1Y total return	-10.43%
200-day SMA	1.19
3Y total return	-54.82%
50-day SMA	1.16
50-day SMA vs 200-day SMA	50under200
5Y total return	-86.79%
All Time High	18.5
All Time High Change	-94.43%
All Time High Date	2000-03-07
All Time Low	0.36
All Time Low Change	186.11%
All Time Low Date	2009-03-03
ATR	0.05
Beta	0.65
Beta1y	0.89
Beta2y	0.91
Ch YTD	-9.65
High	1.04
High52	1.65
High52 Date	2026-01-22
High52ch	-37.5%
Low	1.03
Low52	0.87
Low52 Date	2025-11-13
Low52ch	18.55%
Ma50ch	-10.98%
Premarket Change Percent	0.97
Premarket Price	$1.04
Premarket Volume	229
Price vs 200-day SMA	-13.59%
RSI	41.58
RSI Monthly	40.41
RSI Weekly	42.13
Sharpe ratio	0.16x
Sortino ratio	0.32
Total Return	-3.01%
Tr YTD	-9.65
Tr15y	-73.11%
Tr3m	-29.45%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Earnings EPS Estimate	$-0.07
Earnings Revenue Estimate	11,910,000x
Earnings Revenue Estimate Growth	0.12x
Operating Income	$-2.6M
Operating margin	-4.88

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	11,404,146%
Float Percent	65.56%
Net Borrowing	39,000
Shares Insiders	10.7%
Shares Institutions	12.39%
Shares Out	17,395,350
Shares Qo Q	1.05%
Shares Yo Y	3.01%
Short Float	0.92%
Short Ratio	0.17
Short Shares	0.6

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-3M
Average Volume	71,905.95x
Bv Per Share	-0.06
CAPEX	$-143,000
Ch10y	-90.71
Ch15y	-73.11
Ch1y	-10.43
Ch20y	-91.92
Ch3m	-29.45
Ch3y	-54.82
Ch5y	-86.79
Ch6m	-2.37
Change	0%
Change From Open	-0.96
Close	1.03
Days Gap	0.97
Depreciation Amortization	251,000
Dollar Volume	49,542
Earnings Date	2026-05-19
Earnings Time	amc
EBIT	$-2.6M
EBITDA	$-2.3M
EPS	$-0.26
F Score	3
FCF	$-2.3M
FCF EV Yield	-13.75x
FCF Per Share	$-0.13
Financing CF	5,964,000
Fiscal Year End	January
Founded	1,989
Goodwill	965,000
Income Tax	$57,000
Investing CF	-143,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-26
Last Report Date	2026-01-03
Last Split Type	Never
Last10k Filing Date	2026-04-02
Ma150	1.17
Ma150ch	-11.59%
Ma20	1.05
Ma20ch	-1.53%
Net CF	3,641,000
Next Earnings Date	2026-05-19
Open	1.04
Optionable	Yes
Position In Range	0
Post Close	1.03
Postmarket Change Percent	1.92
Postmarket Price	$1.05
Ppne	826,000
Pre Close	1.03
Price Date	2026-05-08
Relative Volume	0.67x
Revenue	52,675,000x
SBC By Revenue	1.47x
Share Based Comp	775,000
Tax By Revenue	0.11x
Tr20y	-91.92%
Tr6m	-2.37%
Us State	California
Volume	48,099
Z Score	-1.94

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does IRIX pay a dividend?

Capital-return profile for this ticker.

Performance

IRIX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns IRIX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+12.4%

Float: +65.6% of shares outstanding

Insider ownership

+10.7%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

IRIX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

41.6

Neutral momentum band

Price vs 200-day MA

-13.6%

50/200-day relationship not available

Beta (5Y)

0.65

Less volatile than the market

Sharpe ratio

0.16

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About IRIX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current IRIX stock rating?

IRIDEX Corporation is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full IRIX analysis?

The full report lives at /stocks/IRIX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for IRIX?

The latest report frames IRIX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the IRIX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.